Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer. Spanish translation.

Grivas, Petros; Blake-Haskins, John A.; Costa, Nuno; Huang, Bo; Laliberte, Robert J.; Petrylak, Daniel P.; Aragon-Ching, Jeanny B.; Bellmunt, Joaquim; Sternberg, Cora N.; Kopyltsov, Evgeny; Tsuchiya, Norihiko; Sridhar, Srikala S.; Loriot, Yohann; Ullén, Anders; Demey, Wim; Radulović, Sinisa; Kalofonos, Haralabos; Gurney, Howard; Valderrama, Begoña P.; Caserta, Claudia; Voog, Eric; Park, Se-Hoon; Powles, Thomas

doi:10.25402/FON.21437619.v1

Spanish_Final.pdf (1.05 MB)

Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer. Spanish translation.

journal contribution

posted on 2022-10-31, 15:35 authored by Petros Grivas, John A. Blake-Haskins, Nuno Costa, Bo Huang, Robert J. Laliberte, Daniel P. Petrylak, Jeanny B. Aragon-Ching, Joaquim Bellmunt, Cora N. Sternberg, Evgeny Kopyltsov, Norihiko Tsuchiya, Srikala S. Sridhar, Yohann Loriot, Anders Ullén, Wim Demey, Sinisa Radulović, Haralabos Kalofonos, Howard Gurney, Begoña P. Valderrama, Claudia Caserta, Eric Voog, Se-Hoon Park, Thomas Powles

Spanish translation of plain language summary of results from the JAVELIN Bladder 100 study

History

Usage metrics

Keywords

urothelial cancer plain language summary maintenance treatment lay summary JAVELIN Bladder 100 immunotherapy bladder cancer avelumab

Licence

CC BY-NC-ND 4.0

Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer. Spanish translation.

History

Usage metrics

Categories

Keywords

Licence

Exports